HOME >> BIOLOGY >> NEWS
Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University

Snowmass, Co. (September 10, 2004) - Inflammatory Bowel Diseases, comprised of Crohn's Disease and ulcerative colitis, are for the most part incurable and their causes are still unknown. About 1 million Americans suffer from IBD and research around the world on new therapeutic strategies against IBD is being reported at a conference sponsored by the American Physiological Society.

On one thing most researchers agree on about IBD: it's very complex. And though it might seem obvious that treating a complex disease might take more than one agent, use of combination therapy hasn't been discussed much in relation to IBD.

Now separate groups working in Houston/Boston and Jerusalem have considered the implications of combination therapy in IBD. They are presenting their papers at the APS conference.

Intestinal Lactobacillus reuteri-based combination therapy directly modulates mucosal pro-inflammatory cytokine production in IL-10 deficient mice.

Probiotics and commensal bacteria represent likely sources for novel therapeutic strategies in inflammatory bowel diseases, and have become increasingly interesting to researchers. Indeed, some probiotic therapy agents are thought to be nearing the clinical trial stage. It is well-known that the human (and animal) gut is full of mostly beneficial bacteria. In IBD and other diseases researchers have taken an approach that reintroduces these positive bacteria, allow them to repopulate the gut and quite often they produce their own anti-inflammatory chemicals. One of the major such "bugs" is the genus Lactobacillus.

The research reported below was carried by James Versalovic and Jeremy Andrew Pena at the Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, and by Arlin B. Rogers, Zhongming Ge and James G. Fox at the Division of Comparative Medicine at Massachusetts Institute of Technology, Cambridge, Mass.

Probiotics have demonstrated efficacy in treating patients
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Winning combination to build bone density in children
2. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
3. Researchers zero in on new drug combination strategy
4. IUB researchers to investigate genetic recombinations causes and consequences
5. Mutated protein combination tied to excessive sugar production
6. Clinical study reports findings of combination therapy with DOXIL
7. Novel COX-2 combination treatment may reduce colon cancer risk
8. Drug combination increases life span of mice with ALS
9. A combination of zinc and vitamin A may restore night vision in pregnant Nepalese women
10. Alcohol and thiamine deficiency together: a dangerous combination?
11. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... June 04, 2019 , ... ... the appointment of Susan Murphy as the new President of Molecular Devices, replacing ... Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in a ...
(Date:6/4/2019)... ... 2019 , ... Lajollacooks4u is delighted to announce it has been named as ... is given only to businesses that have achieved consistently outstanding traveler reviews on TripAdvisor, ... , To qualify for the Certificate of Excellence –- an award that only 10 ...
(Date:5/31/2019)... INDIANAPOLIS (PRWEB) , ... May 29, 2019 , ... ... and configurations on Mac, Windows and mobile, announces the launch of version 13.1. ... via the latest Android Management API, and supports Apple’s spring release functionality. Version ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... DES MOINES, Iowa (PRWEB) , ... July 08, 2019 , ... ... in Des Moines, Iowa, the National Corn Growers Association (NCGA) announced the ... unique technology to improve a product or process using field corn to produce biobased ...
(Date:7/2/2019)... ... ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , was recently featured in ... on regenerative veterinary medicine as a means of improving the quality of life for ... Brentwood and Pacific Palisades International Film Festival in Los Angeles, California where it received ...
(Date:6/18/2019)... , ... June 17, 2019 , ... ... they have entered into an agreement for production and manufacturing of GMP-grade adeno-associated ... treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, ... been signed. The agreement will grant exclusive rights for Zillion to represent LDA ...
Breaking Biology Technology:
Cached News: